CompletedNot Applicable

Surgeon-performed Outpatient Transoral and Transcervical Ultrasound of the Oropharynx

Denmark201 participantsStarted 2023-02-01

Plain-language summary

The purpose of the study is to compare the sensitivity and specificity of transoral ultrasound, transcervical ultrasound, Magnetic Resonance Imaging (MRI) and Positron Emission Tomography-Computerized Tomography (PET-CT) in terms of detecting primary oropharynx tumors.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Visible and/or palpable tumors of the oropharynx.
✓. Asymmetry of the tonsils or tongue base.
✓. Symptoms including dysphagia, throat pain, and/or referred otalgia where an oropharynx tumor is suspected but not clinically visible.
✓. Suspected cervical lymph node metastasis with no visible/palpable primary tumor.
✓. Lateral neck cysts in patients aged 40+ years.

What they're measuring

Tumors detected by clinical evaluation, ultrasound, MRI, CT, and PET/CT compared to the reference standard histopathology results.

Timeframe: 2 weeks.

Trial details

NCT IDNCT05696314

SponsorRigshospitalet, Denmark

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-07-01

View on ClinicalTrials.gov More Oropharynx Cancer trials